Alternative Forms of the Phosphodiesterase-4 Inhibitor N-Cyclopropyl-1--4-Oxo-1,4-Dihydro-1,8-Naphthyridine-3-Carboxyamide
申请人:Clas Sophie-Dorothee
公开号:US20110245290A1
公开(公告)日:2011-10-06
The present invention is directed to alternative forms of the title phosphodiesterase 4 inhibitor which has the structural formula shown immediately below:
本发明涉及选择性磷酸二酯酶4抑制剂的替代形式,其结构式如下所示:
[EN] ALTERNATIVE FORMS OF THE PHOSPHODIESTERASE-4 INHIBITOR N-CYCLOPROPYL-1-{3-[(1-OXIDOPRYIDIN-3-YL)ETHYNYL]PHENYL}-4-OXO-1,4-DIHYDRO-1,8-NAPHTHYRIDINE-3-CARBOXYAMIDE<br/>[FR] FORMES ALTERNATIVES DU N-CYCLOPROPYL-1-{3-[(1-OXIDOPRYIDIN-3-YL)ETHYNYL]PHENYL}-4-OXO-1,4-DIHYDRO-1,8-NAPHTHYRIDINE-3-CARBOXYAMIDE, UN INHIBITEUR DE PHOSPHODIESTERASE DE TYPE 4
申请人:MERCK FROSST CANADA LTD
公开号:WO2005105084A1
公开(公告)日:2005-11-10
The present invention is directed to alternative forms of the title phosphodiesterase 4 inhibitor which has the structural formula shown immediately below: Compound IX
本发明涉及磷酸二酯酶4抑制剂的替代形式,其结构式如下所示:化合物IX。
Tee, Oswald S.; Paventi, Martino, Canadian Journal of Chemistry, 1983, vol. 61, p. 2556 - 2562